Financials and Filings FINANCIALS AND FILINGS submenu Overview SEC Filings Annuals & Proxies Quarterly Results Key Ratios Show all 2022 Third Quarter Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update Form 10-Q Filing date View November 03, 2022 View HTML 0001193125-22-276406.pdf 0001193125-22-276406.rtf 0001193125-22-276406.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA August 09, 2022 View HTML 0001193125-22-215635.pdf 0001193125-22-215635.rtf 0001193125-22-215635.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-K Filing date View March 01, 2022 View HTML 0001193125-22-059849.pdf 0001193125-22-059849.rtf 0001193125-22-059849.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA February 25, 2021 View HTML 0001193125-21-055751.pdf 0001193125-21-055751.rtf 0001193125-21-055751.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Proxy Statements Filing date View April 21, 2022 View HTML 0001193125-22-113145.pdf 0001193125-22-113145.xls 0001193125-22-113145.rtf April 29, 2021 View HTML 0001193125-21-140765.pdf 0001193125-21-140765.xls 0001193125-21-140765.rtf
